leisure time -WSS

leisure time

author：Wikipedia 2025-09-06 08:39:12 - browse：8743

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Do digital therapeutics have a future in medicine?

hotspot

knowledge

WSS

Do digital therapeutics have a future in medicine?

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Juul spent big to court Black leaders to promote its e

Britney Spears to release memoir, 'The Woman In Me,' later this year

Blinken talks high

Inflation cooled significantly in June, bringing price hikes close to normal levels

hotspot

leisure time

hotspot

Virginia high school admissions case could be legal follow

How are insurers handling Leqembi and related scans?

23andMe had bad news about my health. I wish a person had delivered it

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

State Dept. review finds Biden bears some blame for Afghanistan failures

Blinken talks high

What does generative AI mean for health care? We asked experts

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Duchenne breakthrough therapy leaves behind pioneering families

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

knowledge

A $475,000 price tag for a new cancer drug: crazy or meh?

Superbugs, antibiotic resistance get scrutiny in congress

One Duchenne patient's bittersweet hope for new treatment

New Ultima Genomics DNA sequencer can read genome for $100

New Ultima Genomics DNA sequencer can read genome for $100

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

hotspot

knowledge

focus

hotspot